Annual Total Liabilities
$4.19 M
+$984.10 K+30.68%
31 December 2023
Summary:
Context Therapeutics annual total liabilities is currently $4.19 million, with the most recent change of +$984.10 thousand (+30.68%) on 31 December 2023. During the last 3 years, it has fallen by -$13.20 million (-75.89%). CNTX annual total liabilities is now -82.70% below its all-time high of $24.23 million, reached on 31 December 2019.CNTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$2.47 M
+$867.90 K+54.10%
01 September 2024
Summary:
Context Therapeutics quarterly total liabilities is currently $2.47 million, with the most recent change of +$867.90 thousand (+54.10%) on 01 September 2024. Over the past year, it has dropped by -$2.13 million (-46.30%). CNTX quarterly total liabilities is now -90.29% below its all-time high of $25.47 million, reached on 30 September 2021.CNTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.7% | -46.3% |
| 3 y3 years | -75.9% | -90.3% |
| 5 y5 years | - | - |
CNTX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -75.9% | +38.2% | -90.3% | +54.1% |
| 5 y | 5 years | -82.7% | +38.2% | -90.3% | +54.1% |
| alltime | all time | -82.7% | +38.2% | -90.3% | +54.1% |
Context Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.47 M(+54.1%) |
| June 2024 | - | $1.60 M(-38.5%) |
| Mar 2024 | - | $2.61 M(-37.8%) |
| Dec 2023 | $4.19 M(+30.7%) | $4.19 M(-9.0%) |
| Sept 2023 | - | $4.60 M(+22.5%) |
| June 2023 | - | $3.76 M(+16.2%) |
| Mar 2023 | - | $3.23 M(+0.8%) |
| Dec 2022 | $3.21 M | $3.21 M(-20.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $4.01 M(+31.6%) |
| June 2022 | - | $3.05 M(+86.0%) |
| Mar 2022 | - | $1.64 M(-46.0%) |
| Dec 2021 | $3.03 M(-82.6%) | $3.03 M(-88.1%) |
| Sept 2021 | - | $25.47 M(+1.8%) |
| June 2021 | - | $25.02 M(+26.8%) |
| Mar 2021 | - | $19.73 M(+13.5%) |
| Dec 2020 | $17.39 M(-28.2%) | $17.39 M |
| Dec 2019 | $24.23 M | - |
FAQ
- What is Context Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Context Therapeutics?
- What is Context Therapeutics annual total liabilities year-on-year change?
- What is Context Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Context Therapeutics?
- What is Context Therapeutics quarterly total liabilities year-on-year change?
What is Context Therapeutics annual total liabilities?
The current annual total liabilities of CNTX is $4.19 M
What is the all time high annual total liabilities for Context Therapeutics?
Context Therapeutics all-time high annual total liabilities is $24.23 M
What is Context Therapeutics annual total liabilities year-on-year change?
Over the past year, CNTX annual total liabilities has changed by +$984.10 K (+30.68%)
What is Context Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CNTX is $2.47 M
What is the all time high quarterly total liabilities for Context Therapeutics?
Context Therapeutics all-time high quarterly total liabilities is $25.47 M
What is Context Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CNTX quarterly total liabilities has changed by -$2.13 M (-46.30%)